SEC Form 4 · accession 0001171843-15-004272
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond J Land
Director
Period of report
Jul 30, 2015
Accepted (ET)
Aug 3, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 30, 2015 | S | 690 | $37.39 | D | 14,499 | D | |
| Common StockF1 | Jul 30, 2015 | M | 1,540 | $12.36 | A | 16,039 | D | |
| Common StockF2 | Jul 30, 2015 | F | 522 | $36.51 | D | 15,517 | D | |
| Common Stock | Jul 31, 2015 | S | 1,018 | $37.76 | D | 14,499 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF1 | $12.36 | Jul 30, 2015 | M | 1,540 | D | — | Dec 14, 2016 | Common Stock | 1,540 | 0 | D |
Explanation of responses
- F1Exercise of stock appreciation rights ("SARs") granted on December 14, 2006 vesting in four annual installments beginning December 14, 2007.
- F2Reflects 522 shares of common stock utilized to cover the exercise of the above listed SARs awards by the Reporting Person on July 30, 2015.